Therefore, the transient depletion of Treg, the blocking of IL-10 and TGF-β, the fine control of NKT-derived IFN-γ in the tumor microenvironment may enhance therapeutic HPV vaccine potency. This evidence concerns the gene TGFB1 and neoplasm.